ATLASState Street Health Care Select Sector SPDR ETF (XLV): outlook, holdings and fees
State Street Health Care Select Sector SPDR ETF (XLV) is an exchange-traded fund and is managed by State Street Investment Management. The expense ratio is 0.09% and the yield is 1.56%. The ten largest holdings are 61% of the fund.
Fund data as of Oct 14, 2026 · Price Nov 2, 2026
ATLAS view on XLV
| Last price | $184.55 (-0.2%) |
|---|---|
| ATLAS chance of a higher price in 1 month | 54% |
| Likely 1-month range (50%) | $179.79 – $191.15 |
| Normal 1-day range (±1σ) | ±1.0% |
| Distribution yield | 1.56% |
ATLAS probabilities use the same calibrated model as every stock page. A fair value is shown for companies, not funds; the holdings below link to the fair value of each company.
XLV fund facts
| Issuer | State Street Investment Management |
|---|---|
| Theme | Healthcare |
| Assets under management | $44.3B |
| Expense ratio | 0.09% |
| Number of holdings | 50 |
| Portfolio turnover | 3% |
| Inception | Dec 16, 1998 |
| Exchange | NYSE |
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
XLV top holdings
| Holding | Sector | Weight |
|---|---|---|
| Eli Lilly and Company LLY | Healthcare | 15.84% |
| Johnson & Johnson JNJ | Healthcare | 10.23% |
| AbbVie Inc ABBV | Healthcare | 7.49% |
| Merck & Company Inc MRK | Healthcare | 5.91% |
| UnitedHealth Group Incorporated UNH | Healthcare | 5.28% |
| Thermo Fisher Scientific Inc TMO | Healthcare | 3.99% |
| Amgen Inc AMGN | Healthcare | 3.59% |
| Gilead Sciences Inc GILD | Healthcare | 3.03% |
| Abbott Laboratories ABT | Healthcare | 2.84% |
| Pfizer Inc PFE | Healthcare | 2.65% |
Holdings with an ATLAS page link to their probability range, fair value and earnings calendar.
XLV sector breakdown
| Sector | Weight |
|---|---|
| Healthcare | 100.0% |
By region: North America 100.0%.
XLV returns and risk
| Year to date | +11.8% |
|---|---|
| 1 year | +19.5% |
| 3 years (annualised) | +10.7% |
| 5 years (annualised) | +7.7% |
| 10 years (annualised) | +10.4% |
| Volatility (3 years) | 14.2% |
| Sharpe ratio (3 years) | 0.48 |
Past returns do not guarantee future results.
XLV: frequently asked questions
What does XLV invest in?
State Street Health Care Select Sector SPDR ETF invests in a portfolio of securities. Its largest holdings are Eli Lilly and Company (15.8%), Johnson & Johnson (10.2%), AbbVie Inc (7.5%), Merck & Company Inc (5.9%), UnitedHealth Group Incorporated (5.3%).
What is the XLV expense ratio?
0.09% a year: about $9.00 for every $10,000 invested.
What is the XLV dividend yield?
1.56%. ATLAS does not hold the exact distribution dates for ETFs.
Will XLV go up?
Nobody can know. The ATLAS model puts the chance of a higher price in one month at 54%, with a likely range (50%) of $179.79 to $191.15 from $184.55 today. It is a probability, not a prediction.
How has XLV performed?
Year to date +11.8%, one year +19.5%, three years +10.7% a year, five years +7.7% a year. Past returns do not guarantee future results.
Similar ETFs: Healthcare
- Vanguard Health Care ETF (VHT)
- iShares Global Healthcare ETF (IXJ)
- iShares U.S. Healthcare ETF (IYH)
- iShares U.S. Medical Devices ETF (IHI)
- Fidelity MSCI Health Care Index ETF (FHLC)
- iShares U.S. Pharmaceuticals ETF (IHE)
- First Trust Health Care AlphaDEX Fund (FXH)
- First Trust Nasdaq Pharmaceuticals ETF (FTXH)
Educational information, not investment advice. Disclaimer